Bliss GVS Pharma Ownership Transfer Finalized

Effective September 28, 2026, Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited have assumed control of Bliss GVS Pharma Ltd. This follows the successful completion of an open offer and the Share Purchase Agreement executed on May 23, 2026.

Reader Takeaway: The transition to new ownership is complete, with previous promoters reclassified as public shareholders per SEBI regulations.

What just happened

The Board of Directors of Bliss GVS Pharma Ltd formally acknowledged the shift in corporate control during their meeting on September 28, 2026. This administrative milestone confirms that the acquisition process, which began in May, has concluded in full compliance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Why this matters

For investors, this filing signifies the official end of the ownership transition period. The company now operates under the governance and strategic direction of Anupam Rasayan India and its affiliates. As a result of this change, the erstwhile promoters and the former promoter group have been reclassified into the public category under Regulation 31A(10) of the SEBI Listing Regulations.

The new promoter structure

Anupam Rasayan India Limited and Mates Visa Consultancy Pvt. Ltd. are now designated as the company’s Promoters. The updated Promoter Group includes various entities under the Anupam Rasayan umbrella, such as Tanfac Industries Limited, Jayhawk Fine Chemicals Corporation, and several international holding entities including Kansas HoldCo Inc. and Anupam Europe AG.

What to track next

Shareholders should monitor for any subsequent changes in company strategy or board composition that may follow the formal integration of the new promoter group. All regulatory filings now reflect the current ownership status.